New
Bioscience Equity Partners
The AI engine Fit Assessment
BetaThe company will be attending the 2024 Health Tech Forward Event
Blurb
Bioscience Equity Partners focus exclusively on compelling Med Tech and Biosciences investment themes and ventures.
HQ Location
United States
Founded
2022
Employees
11 - 50
Total funding raised
Not available
Last Funding Event
Not available
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Bioscience Equity Partners is an international investment bank firm strongly affiliated with several global VC funds and with an exclusive focus on early-stage biotechnology, med-tech, and digital health.
We partner with these early-stage bioscience ventures throughout their development journey providing venture capital, corporate finance, advisory and investment banking services to take them to the Capital Markets. Bioscience Equity Partners is a member of the Arab Federation of Capital Markets (FACM).